| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Neoplastic Stem Cells | 3 | 2017 | 172 | 0.990 |
Why?
|
| Neuroblastoma | 3 | 2017 | 400 | 0.910 |
Why?
|
| Proto-Oncogene Proteins c-myc | 3 | 2019 | 152 | 0.630 |
Why?
|
| Polycomb Repressive Complex 2 | 1 | 2017 | 32 | 0.530 |
Why?
|
| Sulfoxides | 1 | 2017 | 6 | 0.520 |
Why?
|
| Gene Expression Profiling | 5 | 2017 | 1535 | 0.520 |
Why?
|
| Genes, myc | 1 | 2017 | 41 | 0.510 |
Why?
|
| Transcriptome | 4 | 2018 | 769 | 0.500 |
Why?
|
| Hematopoietic Stem Cells | 2 | 2015 | 327 | 0.470 |
Why?
|
| Pyrimidines | 2 | 2019 | 386 | 0.460 |
Why?
|
| Immunotherapy | 3 | 2019 | 766 | 0.440 |
Why?
|
| Porphobilinogen Synthase | 1 | 2012 | 4 | 0.390 |
Why?
|
| Gene Expression Regulation, Neoplastic | 3 | 2019 | 1346 | 0.380 |
Why?
|
| Gene Regulatory Networks | 1 | 2015 | 322 | 0.370 |
Why?
|
| Genomics | 2 | 2017 | 857 | 0.370 |
Why?
|
| Kruppel-Like Transcription Factors | 1 | 2012 | 109 | 0.360 |
Why?
|
| Stem Cell Transplantation | 1 | 2013 | 193 | 0.350 |
Why?
|
| Leukemia, Myeloid, Acute | 2 | 2015 | 841 | 0.340 |
Why?
|
| Carcinoma, Renal Cell | 2 | 2025 | 367 | 0.290 |
Why?
|
| Hematologic Neoplasms | 1 | 2013 | 372 | 0.290 |
Why?
|
| Cell Line, Tumor | 6 | 2017 | 2778 | 0.280 |
Why?
|
| DNA-Binding Proteins | 2 | 2013 | 1267 | 0.270 |
Why?
|
| Kidney Neoplasms | 2 | 2025 | 558 | 0.270 |
Why?
|
| Risk | 3 | 2017 | 668 | 0.260 |
Why?
|
| Antineoplastic Agents | 2 | 2018 | 2418 | 0.250 |
Why?
|
| Promoter Regions, Genetic | 4 | 2013 | 996 | 0.240 |
Why?
|
| Transcription Factors | 2 | 2013 | 1730 | 0.230 |
Why?
|
| Copper | 1 | 2025 | 81 | 0.220 |
Why?
|
| Gene Silencing | 2 | 2017 | 181 | 0.200 |
Why?
|
| Prognosis | 3 | 2017 | 4028 | 0.200 |
Why?
|
| Pituitary Hormones | 1 | 2002 | 7 | 0.190 |
Why?
|
| Adrenocortical Hyperfunction | 1 | 2002 | 6 | 0.190 |
Why?
|
| Cushing Syndrome | 1 | 2002 | 25 | 0.190 |
Why?
|
| Adrenocorticotropic Hormone | 1 | 2002 | 132 | 0.190 |
Why?
|
| Mice | 12 | 2025 | 12537 | 0.180 |
Why?
|
| Homeodomain Proteins | 2 | 2017 | 563 | 0.180 |
Why?
|
| Cardiomegaly | 2 | 2012 | 122 | 0.170 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p16 | 2 | 2012 | 107 | 0.170 |
Why?
|
| Tobacco Smoking | 1 | 2021 | 31 | 0.170 |
Why?
|
| Cellular Reprogramming | 1 | 2021 | 51 | 0.160 |
Why?
|
| Circadian Rhythm | 1 | 2002 | 300 | 0.160 |
Why?
|
| Animals | 14 | 2025 | 28891 | 0.150 |
Why?
|
| Child | 5 | 2017 | 7625 | 0.150 |
Why?
|
| Cell Transformation, Neoplastic | 2 | 2012 | 465 | 0.150 |
Why?
|
| Breast Neoplasms | 1 | 2013 | 3157 | 0.150 |
Why?
|
| Protein Biosynthesis | 2 | 2019 | 399 | 0.140 |
Why?
|
| Histones | 2 | 2012 | 363 | 0.140 |
Why?
|
| Eukaryotic Initiation Factor-2 | 1 | 2018 | 18 | 0.140 |
Why?
|
| Humans | 21 | 2025 | 96105 | 0.140 |
Why?
|
| Disease Progression | 3 | 2025 | 1562 | 0.140 |
Why?
|
| Transferrin | 1 | 2016 | 21 | 0.130 |
Why?
|
| Acute Chest Syndrome | 1 | 2017 | 24 | 0.130 |
Why?
|
| Mechanistic Target of Rapamycin Complex 1 | 1 | 2016 | 45 | 0.130 |
Why?
|
| Embryonic Stem Cells | 1 | 2017 | 87 | 0.130 |
Why?
|
| Exosomes | 1 | 2017 | 60 | 0.120 |
Why?
|
| Pharmacogenomic Testing | 1 | 2017 | 107 | 0.120 |
Why?
|
| Molecular Imaging | 1 | 2016 | 72 | 0.120 |
Why?
|
| Exons | 1 | 2017 | 454 | 0.120 |
Why?
|
| Recovery of Function | 1 | 2017 | 348 | 0.120 |
Why?
|
| RNA Polymerase II | 2 | 2012 | 62 | 0.120 |
Why?
|
| Cell Proliferation | 3 | 2017 | 1753 | 0.120 |
Why?
|
| TOR Serine-Threonine Kinases | 1 | 2016 | 217 | 0.110 |
Why?
|
| Protein Binding | 3 | 2013 | 1560 | 0.100 |
Why?
|
| Base Sequence | 2 | 2019 | 2344 | 0.100 |
Why?
|
| Citric Acid | 1 | 2013 | 48 | 0.100 |
Why?
|
| Position-Specific Scoring Matrices | 1 | 2013 | 5 | 0.100 |
Why?
|
| Neoplasm Metastasis | 2 | 2019 | 1094 | 0.100 |
Why?
|
| Adiponectin | 1 | 2013 | 21 | 0.100 |
Why?
|
| Graft vs Leukemia Effect | 1 | 2013 | 11 | 0.100 |
Why?
|
| Metabolism, Inborn Errors | 1 | 2013 | 31 | 0.100 |
Why?
|
| Child, Preschool | 3 | 2017 | 3974 | 0.100 |
Why?
|
| Cell Separation | 1 | 2013 | 205 | 0.100 |
Why?
|
| Nucleotide Motifs | 1 | 2013 | 49 | 0.100 |
Why?
|
| Apoptosis | 2 | 2017 | 1756 | 0.100 |
Why?
|
| Oncogene Protein v-akt | 1 | 2012 | 21 | 0.100 |
Why?
|
| Infant | 3 | 2017 | 3363 | 0.100 |
Why?
|
| Burkitt Lymphoma | 1 | 2012 | 34 | 0.100 |
Why?
|
| Electrophoretic Mobility Shift Assay | 1 | 2012 | 75 | 0.100 |
Why?
|
| Receptor, Platelet-Derived Growth Factor beta | 1 | 2012 | 27 | 0.100 |
Why?
|
| Chromosomes, Human, Pair 7 | 1 | 2012 | 81 | 0.090 |
Why?
|
| Heparin | 1 | 2013 | 186 | 0.090 |
Why?
|
| Liver Neoplasms | 1 | 2019 | 793 | 0.090 |
Why?
|
| Chromatin Immunoprecipitation | 1 | 2012 | 142 | 0.090 |
Why?
|
| JNK Mitogen-Activated Protein Kinases | 1 | 2012 | 113 | 0.090 |
Why?
|
| Chromosome Deletion | 1 | 2012 | 229 | 0.090 |
Why?
|
| Eye | 1 | 2012 | 112 | 0.090 |
Why?
|
| Diet, High-Fat | 1 | 2013 | 134 | 0.090 |
Why?
|
| Allografts | 1 | 2013 | 207 | 0.090 |
Why?
|
| Tamoxifen | 1 | 2012 | 171 | 0.090 |
Why?
|
| Metabolic Syndrome | 1 | 2013 | 123 | 0.090 |
Why?
|
| DNA Primers | 1 | 2012 | 548 | 0.090 |
Why?
|
| Leukemia, Myeloid | 1 | 2012 | 252 | 0.090 |
Why?
|
| Sirtuins | 1 | 2012 | 80 | 0.090 |
Why?
|
| Computational Biology | 1 | 2015 | 586 | 0.090 |
Why?
|
| Antibodies, Monoclonal | 1 | 2017 | 1429 | 0.090 |
Why?
|
| High-Throughput Nucleotide Sequencing | 1 | 2015 | 540 | 0.090 |
Why?
|
| Prenatal Exposure Delayed Effects | 1 | 2013 | 176 | 0.090 |
Why?
|
| Peripheral Blood Stem Cell Transplantation | 1 | 2011 | 67 | 0.090 |
Why?
|
| Cell Line | 2 | 2012 | 2537 | 0.090 |
Why?
|
| Sirtuin 1 | 1 | 2011 | 37 | 0.090 |
Why?
|
| Signal Transduction | 4 | 2015 | 3581 | 0.080 |
Why?
|
| Hematopoietic Stem Cell Transplantation | 1 | 2017 | 943 | 0.080 |
Why?
|
| Software | 1 | 2015 | 698 | 0.080 |
Why?
|
| Cell Differentiation | 1 | 2017 | 1667 | 0.080 |
Why?
|
| Autophagy | 1 | 2012 | 175 | 0.080 |
Why?
|
| Smad3 Protein | 1 | 2010 | 25 | 0.080 |
Why?
|
| Smad2 Protein | 1 | 2010 | 24 | 0.080 |
Why?
|
| Cord Blood Stem Cell Transplantation | 1 | 2011 | 91 | 0.080 |
Why?
|
| Polymerase Chain Reaction | 1 | 2012 | 930 | 0.080 |
Why?
|
| p38 Mitogen-Activated Protein Kinases | 1 | 2010 | 126 | 0.080 |
Why?
|
| Disease-Free Survival | 1 | 2013 | 1196 | 0.080 |
Why?
|
| Binding Sites | 1 | 2013 | 1167 | 0.080 |
Why?
|
| Genome, Human | 1 | 2015 | 824 | 0.080 |
Why?
|
| Anticoagulants | 1 | 2013 | 463 | 0.080 |
Why?
|
| Proto-Oncogene Proteins c-akt | 1 | 2011 | 367 | 0.080 |
Why?
|
| Recurrence | 1 | 2013 | 1218 | 0.080 |
Why?
|
| Transplantation Conditioning | 1 | 2011 | 383 | 0.080 |
Why?
|
| Repressor Proteins | 1 | 2012 | 447 | 0.080 |
Why?
|
| Graft vs Host Disease | 1 | 2011 | 368 | 0.080 |
Why?
|
| Tumor Suppressor Protein p53 | 1 | 2012 | 465 | 0.080 |
Why?
|
| Protein Methyltransferases | 1 | 2009 | 15 | 0.070 |
Why?
|
| DNA (Cytosine-5-)-Methyltransferases | 1 | 2009 | 61 | 0.070 |
Why?
|
| Cell Membrane | 1 | 2011 | 695 | 0.070 |
Why?
|
| Transforming Growth Factor beta | 1 | 2010 | 349 | 0.070 |
Why?
|
| Age Factors | 1 | 2013 | 1963 | 0.070 |
Why?
|
| Nuclear Proteins | 1 | 2012 | 750 | 0.070 |
Why?
|
| Acetylation | 3 | 2013 | 149 | 0.070 |
Why?
|
| DNA Methylation | 2 | 2011 | 703 | 0.070 |
Why?
|
| Graft Survival | 1 | 2011 | 942 | 0.070 |
Why?
|
| Mutation | 2 | 2017 | 4374 | 0.070 |
Why?
|
| Female | 9 | 2021 | 50028 | 0.070 |
Why?
|
| Time Factors | 2 | 2013 | 5580 | 0.060 |
Why?
|
| Prostatic Neoplasms | 1 | 2018 | 1798 | 0.060 |
Why?
|
| Mice, Inbred C57BL | 4 | 2019 | 3489 | 0.060 |
Why?
|
| Algorithms | 1 | 2015 | 2015 | 0.060 |
Why?
|
| Unfolded Protein Response | 2 | 2018 | 48 | 0.060 |
Why?
|
| Biomarkers, Tumor | 1 | 2013 | 1670 | 0.050 |
Why?
|
| Mice, Transgenic | 3 | 2012 | 1645 | 0.050 |
Why?
|
| Male | 8 | 2021 | 45863 | 0.050 |
Why?
|
| Xenograft Model Antitumor Assays | 2 | 2016 | 528 | 0.050 |
Why?
|
| Pulsatile Flow | 1 | 2002 | 52 | 0.050 |
Why?
|
| Mice, Knockout | 3 | 2012 | 2161 | 0.050 |
Why?
|
| Adolescent | 3 | 2017 | 9895 | 0.050 |
Why?
|
| Heart Failure | 1 | 2012 | 1422 | 0.050 |
Why?
|
| Risk Factors | 1 | 2013 | 5961 | 0.050 |
Why?
|
| Transcription, Genetic | 2 | 2019 | 1192 | 0.040 |
Why?
|
| Adrenal Cortex Hormones | 1 | 2002 | 294 | 0.040 |
Why?
|
| HeLa Cells | 2 | 2012 | 522 | 0.040 |
Why?
|
| RNA Interference | 2 | 2012 | 385 | 0.040 |
Why?
|
| Blotting, Western | 2 | 2012 | 796 | 0.040 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 2 | 2012 | 897 | 0.040 |
Why?
|
| Treatment Outcome | 1 | 2013 | 9175 | 0.040 |
Why?
|
| Eukaryotic Initiation Factor-4E | 1 | 2019 | 18 | 0.040 |
Why?
|
| Cells, Cultured | 2 | 2017 | 2939 | 0.040 |
Why?
|
| RNA, Messenger | 2 | 2017 | 2090 | 0.040 |
Why?
|
| 5' Untranslated Regions | 1 | 2019 | 54 | 0.040 |
Why?
|
| Immune Evasion | 1 | 2019 | 37 | 0.040 |
Why?
|
| Open Reading Frames | 1 | 2019 | 124 | 0.040 |
Why?
|
| Diagnosis, Differential | 1 | 2002 | 1619 | 0.040 |
Why?
|
| Adult | 4 | 2017 | 28721 | 0.030 |
Why?
|
| Autografts | 1 | 2017 | 33 | 0.030 |
Why?
|
| Epigenesis, Genetic | 2 | 2013 | 555 | 0.030 |
Why?
|
| Proto-Oncogene Proteins p21(ras) | 1 | 2019 | 180 | 0.030 |
Why?
|
| Down-Regulation | 1 | 2019 | 526 | 0.030 |
Why?
|
| Zirconium | 1 | 2016 | 2 | 0.030 |
Why?
|
| RNA, Long Noncoding | 1 | 2018 | 130 | 0.030 |
Why?
|
| Nitric Oxide Synthase Type III | 1 | 2017 | 85 | 0.030 |
Why?
|
| Pyridines | 1 | 2019 | 319 | 0.030 |
Why?
|
| B7-H1 Antigen | 1 | 2019 | 305 | 0.030 |
Why?
|
| Kaplan-Meier Estimate | 1 | 2019 | 883 | 0.030 |
Why?
|
| Up-Regulation | 1 | 2019 | 740 | 0.030 |
Why?
|
| Radiopharmaceuticals | 1 | 2016 | 204 | 0.030 |
Why?
|
| Anemia, Sickle Cell | 1 | 2017 | 150 | 0.030 |
Why?
|
| Positron-Emission Tomography | 1 | 2016 | 353 | 0.030 |
Why?
|
| Tumor Microenvironment | 1 | 2019 | 555 | 0.030 |
Why?
|
| Endothelial Cells | 1 | 2017 | 477 | 0.030 |
Why?
|
| User-Computer Interface | 1 | 2015 | 196 | 0.030 |
Why?
|
| Databases, Genetic | 1 | 2015 | 284 | 0.030 |
Why?
|
| Interleukin Receptor Common gamma Subunit | 1 | 2012 | 13 | 0.020 |
Why?
|
| U937 Cells | 1 | 2012 | 32 | 0.020 |
Why?
|
| K562 Cells | 1 | 2012 | 49 | 0.020 |
Why?
|
| Pericytes | 1 | 2012 | 14 | 0.020 |
Why?
|
| ADP-Ribosylation Factors | 1 | 2012 | 11 | 0.020 |
Why?
|
| Histone Demethylases | 1 | 2012 | 34 | 0.020 |
Why?
|
| Ribosomal Proteins | 1 | 2012 | 45 | 0.020 |
Why?
|
| Gene Knockout Techniques | 1 | 2012 | 85 | 0.020 |
Why?
|
| Leptin | 1 | 2013 | 102 | 0.020 |
Why?
|
| eIF-2 Kinase | 1 | 2012 | 50 | 0.020 |
Why?
|
| Glucose Tolerance Test | 1 | 2013 | 235 | 0.020 |
Why?
|
| Proto-Oncogene Proteins c-mdm2 | 1 | 2012 | 34 | 0.020 |
Why?
|
| Caspases | 1 | 2012 | 156 | 0.020 |
Why?
|
| Haploinsufficiency | 1 | 2012 | 69 | 0.020 |
Why?
|
| Mice, Inbred NOD | 1 | 2012 | 215 | 0.020 |
Why?
|
| Endoplasmic Reticulum Stress | 1 | 2012 | 91 | 0.020 |
Why?
|
| Mice, SCID | 1 | 2012 | 279 | 0.020 |
Why?
|
| Young Adult | 2 | 2017 | 7025 | 0.020 |
Why?
|
| Insulin-Like Growth Factor I | 1 | 2012 | 116 | 0.020 |
Why?
|
| Translocation, Genetic | 1 | 2012 | 263 | 0.020 |
Why?
|
| Calcium Signaling | 1 | 2012 | 142 | 0.020 |
Why?
|
| 3-Phosphoinositide-Dependent Protein Kinases | 1 | 2011 | 5 | 0.020 |
Why?
|
| Heterozygote | 1 | 2012 | 382 | 0.020 |
Why?
|
| Phosphatidylinositol Phosphates | 1 | 2011 | 16 | 0.020 |
Why?
|
| Cluster Analysis | 1 | 2012 | 393 | 0.020 |
Why?
|
| Body Weight | 1 | 2013 | 460 | 0.020 |
Why?
|
| Animals, Newborn | 1 | 2013 | 535 | 0.020 |
Why?
|
| Adult Stem Cells | 1 | 2011 | 32 | 0.020 |
Why?
|
| Cross-Sectional Studies | 1 | 2017 | 1876 | 0.020 |
Why?
|
| Antigens, CD34 | 1 | 2011 | 163 | 0.020 |
Why?
|
| Tumor Suppressor Proteins | 1 | 2012 | 301 | 0.020 |
Why?
|
| Acute Disease | 1 | 2012 | 872 | 0.020 |
Why?
|
| Mice, 129 Strain | 1 | 2010 | 57 | 0.020 |
Why?
|
| Receptors, Transforming Growth Factor beta | 1 | 2010 | 52 | 0.020 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2012 | 701 | 0.020 |
Why?
|
| Insulin Resistance | 1 | 2013 | 380 | 0.020 |
Why?
|
| Cell Survival | 1 | 2012 | 1030 | 0.020 |
Why?
|
| Aged | 2 | 2011 | 20968 | 0.020 |
Why?
|
| Cohort Studies | 1 | 2017 | 3110 | 0.020 |
Why?
|
| Embryo, Mammalian | 1 | 2010 | 224 | 0.020 |
Why?
|
| Enzyme Activation | 1 | 2011 | 692 | 0.020 |
Why?
|
| Illinois | 1 | 2011 | 531 | 0.020 |
Why?
|
| Remission Induction | 1 | 2011 | 769 | 0.020 |
Why?
|
| Haplotypes | 1 | 2011 | 650 | 0.020 |
Why?
|
| Chromatin | 1 | 2012 | 450 | 0.020 |
Why?
|
| Transplantation, Homologous | 1 | 2011 | 1023 | 0.020 |
Why?
|
| HEK293 Cells | 1 | 2011 | 706 | 0.020 |
Why?
|
| Erythroid Precursor Cells | 1 | 2009 | 33 | 0.020 |
Why?
|
| Protein-Arginine N-Methyltransferases | 1 | 2009 | 22 | 0.020 |
Why?
|
| Protein Interaction Domains and Motifs | 1 | 2009 | 91 | 0.020 |
Why?
|
| Phosphorylation | 1 | 2011 | 1157 | 0.020 |
Why?
|
| Pilot Projects | 1 | 2011 | 938 | 0.020 |
Why?
|
| Arginine | 1 | 2009 | 144 | 0.020 |
Why?
|
| Middle Aged | 2 | 2011 | 28368 | 0.020 |
Why?
|
| Gene Knockdown Techniques | 1 | 2009 | 256 | 0.020 |
Why?
|
| Liver | 1 | 2013 | 1238 | 0.020 |
Why?
|
| Survival Analysis | 1 | 2011 | 1546 | 0.020 |
Why?
|
| Drosophila melanogaster | 1 | 2012 | 634 | 0.020 |
Why?
|
| Insulin | 1 | 2013 | 1190 | 0.020 |
Why?
|
| Enzyme Inhibitors | 1 | 2010 | 656 | 0.020 |
Why?
|
| Fibroblasts | 1 | 2010 | 777 | 0.020 |
Why?
|
| Incidence | 1 | 2011 | 1715 | 0.020 |
Why?
|
| Gene Expression | 1 | 2010 | 1320 | 0.020 |
Why?
|
| Phenotype | 1 | 2013 | 2578 | 0.020 |
Why?
|
| Membrane Proteins | 1 | 2012 | 1276 | 0.010 |
Why?
|
| Pregnancy | 1 | 2013 | 3240 | 0.010 |
Why?
|
| Retrospective Studies | 1 | 2017 | 10287 | 0.010 |
Why?
|
| Genome-Wide Association Study | 1 | 2011 | 1765 | 0.010 |
Why?
|
| Polymorphism, Single Nucleotide | 1 | 2011 | 2494 | 0.010 |
Why?
|
| Models, Biological | 1 | 2009 | 1809 | 0.010 |
Why?
|